Reported Earlier, BlossomHill Therapeutics Prices Upsized $150M Initial Public Offering Of 9.375M Shares At $16.00 Per Share,
Share
Why It Matters
BlossomHill Therapeutics is a new company selling shares to the public for the first time, raising $150 million at $16 per share. When a company goes public, it means people can now buy pieces of it on the stock market—watch how the stock trades to see if people think it's a good company.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.